Inventor · disambiguated record
Per-Johan Jakobsson
Also filed as: JAKOBSSON PER-JOHAN
4 granted patents·7 pending applications·14 citations·filing 1999–2022
71Inventor score
Files withKAROLINSKA INNOVATIONS AB4GESYNTA PHARMA AB2BLOMQVIST ANDERS1NOVASAID AB1SAMSARA MEDICIN AB1
Top patents by PatentIndex Score
11 records- 0166US7192733B2Methods and means for modulating PGE synthase activityKAROLINSKA INNOVATIONS AB·Filed 2004·Granted Mar 20, 2007·3 cites·2 claims
- 0261US7067296B2Methods and means for modulating PGE synthase activityKAROLINSKA INNOVATIONS AB·Filed 2002·Granted Jun 27, 2006·1 cites·5 claims
- 0360US2022218670A1Methods of treating diseases characterised by vasoconstrictionGESYNTA PHARMA AB·Filed 2022·Application pending·0 cites
- 0458US7645601B2Methods and means for modulating PGE synthase activityKAROLINSKA INNOVATIONS AB·Filed 2007·Granted Jan 12, 2010·0 cites·19 claims
- 0554US6395502B1Method and means for modulating PGE synthase activityKAROLINSKA INNOVATIONS AB·Filed 1999·Granted May 28, 2002·10 cites·22 claims
- 0654US2011008258A1Methods relating to breathing disordersSAMSARA MEDICIN AB·Filed 2008·Application pending·0 cites
- 0753US2011207113A1Protein structure and method of using protein structureNOVASAID AB·Filed 2009·Application pending·0 cites
- 0848US2019038603A1Methods of treating diseases characterised by vasoconstrictionGESYNTA PHARMA AB·Filed 2017·Application pending·0 cites
- 0942US2020123620A1MiRNA-574-5p AS A BIOMARKER FOR STRATIFICATION OF PROSTAGLANDIN E-DEPENDENT TUMORSSTEINHILBER DIETER·Filed 2018·Application pending·0 cites
- 1040US2007099857A1Methods and means for inhibiting feverBLOMQVIST ANDERS·Filed 2004·Application pending·0 cites
- 1135US2003157084A1Methods for preparing purified prostaglandin E synthaseFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Per-Johan Jakobsson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →